Treatment of multiple sclerosis using interferon-tau

Details for Australian Patent Application No. 2006326688 (hide)

Owner Pepgen Corporation

Inventors Liu, Chih-Ping; Villarete, Lorelie H.

Agent FB Rice

Pub. Number AU-A-2006326688

PCT Pub. Number WO2007/070385

Priority 11/298,972 09.12.05 US

Filing date 8 December 2006

Wipo publication date 21 June 2007

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/070385 Priority application(s): WO2007/070385

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326694-Method and material for manufacturing electrically conductive patterns, including radio frequency identification (RFID) antennas

2006326672-Embedded rule engine for rendering text and other applications